2008;29(2):47–62.PubMedPubMedCentral 30. Inker LA, Schmid CH, Tighiouart H, Eckfeldt JH, Feldman HI, Greene T, et al. Estimating glomerular filtration rate from serum creatinine Caspase Inhibitor VI ic50 and cystatin C. N Engl J Med. 2012;367(1):20–9. doi:10.1056/NEJMoa1114248.PubMedCrossRef 31. Schaeffner ES, Ebert N, Delanaye P, Frei U, Gaedeke J, Jakob O, et al. Two novel equations to estimate kidney function in persons aged 70 years or older. Ann Intern Med. 2012;157(7):471–81. doi:10.7326/0003-4819-157-7-201210020-00003.PubMedCrossRef 32. Chin PK, Vella-Brincat JW, Walker SL, Barclay ML, Begg EJ. Dosing of dabigatran etexilate in relation to renal function and drug interactions at a tertiary
hospital. Intern Med J. 2013;43(7):778–83. doi:10.1111/imj.12170.PubMedCrossRef 33. Lip GY, Nieuwlaat R, Pisters R, Lane DA, TGF-beta/Smad inhibitor Crijns HJ. Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the Euro Heart Survey on atrial fibrillation. Chest. 2010;137(2):263–72. doi:10.1378/chest.09-1584.PubMedCrossRef 34. Pisters R, Lane DA, Nieuwlaat R, de Vos CB, Crijns HJ, Lip GY. A novel user-friendly score (HAS-BLED) to assess 1-year risk of major bleeding in patients with atrial fibrillation: the Euro Heart Survey. Chest.
2010;138(5):1093–100. doi:10.1378/chest.10-0134.PubMedCrossRef 35. Mathew TH. Chronic kidney disease and automatic reporting of estimated glomerular filtration rate: a position statement. Med J Aust. 2005;183(3):138–41.PubMed 36. Stevens LA, Levey AS. Use of the MDRD study equation to estimate kidney function for drug dosing. Clin Pharmacol Ther. 2009;86(5):465–7. doi:10.1038/clpt.2009.124.PubMedCrossRef PF-6463922 solubility dmso 37. Spruill WJ, Wade WE, Cobb HH 3rd. Continuing the use of
the Cockcroft–Gault equation for drug dosing in patients with impaired renal function. Clin Pharmacol Ther. 2009;86(5):468–70. doi:10.1038/clpt.2009.187.PubMedCrossRef 38. Chin PK, Florkowski CM, Begg EJ. The performances of the Cockcroft–Gault, modification of diet in renal disease study and chronic kidney disease epidemiology collaboration equations in predicting gentamicin clearance. PAK5 Ann Clin Biochem. 2013;50(Pt 6):546–57. doi:10.1177/0004563213492320.PubMedCrossRef 39. Mosteller RD. Simplified calculation of body-surface area. N Engl J Med. 1987;317(17):1098. doi:10.1056/NEJM198710223171717.PubMed 40. Selvin E, Juraschek SP, Eckfeldt J, Levey AS, Inker LA, Coresh J. Within-person variability in kidney measures. Am J Kidney Dis. 2013;61(5):716–22. doi:10.1053/j.ajkd.2012.11.048.PubMedCrossRefPubMedCentral 41. Chew-Harris JS, Florkowski CM, George PM, Elmslie JL, Endre ZH. The relative effects of fat versus muscle mass on cystatin C and estimates of renal function in healthy young men. Ann Clin Biochem. 2013;50(Pt 1):39–46. doi:10.1258/acb.2012.011241.PubMedCrossRef 42. Shlipak MG, Mattes MD, Peralta CA. Update on cystatin C: incorporation into clinical practice. Am J Kidney Dis.